Melatonin
Melatonin is supplied as a reference compound for circadian-signaling and antioxidant/free-radical pathway research. Supplied strictly for laboratory and educational research. Not for human or veterinary use.
Vial amount
Purchase option
Checkout includes a research-use attestation. Materials are supplied only for laboratory and educational research.
Melatonin in research
Melatonin is supplied as a reference compound for circadian-signaling and antioxidant/free-radical pathway research.
General RUO catalog item for documented laboratory workflows.
Bench context
Supplied as a research-grade reference material for documented laboratory and educational research workflows.
Available amounts
Select from the stocked vial amounts for Melatonin before adding the material to cart.
Claims discipline
No protocol instructions, no dosing, no medical advice, and no therapeutic or human-use promises.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for diagnostic or therapeutic use, not a drug or supplement.
No supplier listing text is on file yet for this item.
The full research picture, clearly labeled
BioRegen reports the entire research landscape for this compound across four clearly separated tiers, strongest evidence first. Lower tiers, including community and anecdotal reports, are labeled as such and are not BioRegen claims.
Melatonin has one of the larger human evidence bases among compounds in this library, with numerous randomized controlled trials and several meta-analyses published in the peer-reviewed literature on sleep onset latency, circadian rhythm phase shifting, and jet lag. Investigators and systematic reviewers (for example, Cochrane reviews on jet lag and various sleep-medicine meta-analyses) generally report that effects on sleep onset are statistically detectable but modest in size, and that benefits are most consistent for circadian-realignment uses such as jet lag and delayed sleep phase rather than for general insomnia. Reported tolerability in these trials is typically described as good at the doses studied, though authors note heterogeneity in dosing, timing, and study quality. These are findings reported by independent researchers and are summarized here as third-party human evidence, not as a BioRegen claim.
In laboratory and animal research, melatonin is studied as the principal hormone of the pineal gland and as a signal that communicates darkness to the circadian system, acting largely through MT1 and MT2 melatonin receptors. Preclinical investigators have also examined its direct and indirect antioxidant behavior and its interactions with the suprachiasmatic nucleus in rodent and in vitro models. This preclinical work is reported by research groups and describes mechanisms observed in laboratory systems.
In biohacker communities, longevity forums, and mainstream media health coverage, melatonin is among the most widely discussed supplements, with frequent discussion of using it for sleep, shift work, and travel, and recurring debate about typical over-the-counter doses being higher than the amounts used in many clinical studies. Such commentary reflects unverified anecdotal commentary, not controlled data, and not a BioRegen claim.
In the United States, melatonin is marketed as an over-the-counter dietary supplement and is not an FDA-approved drug, meaning it is not reviewed by the FDA for efficacy or safety as a medicine. In some other countries a prescription melatonin product exists (for example, prolonged-release melatonin marketed as Circadin in parts of Europe), reflecting different national regulatory classifications. BioRegen supplies it strictly for laboratory and educational research, not for human use.
Tiers are evidence categories, not endorsements. Clinical and preclinical entries summarize third-party published research. Community and anecdotal entries are unverified reports discussed by others, not findings and not BioRegen claims. Nothing here is medical advice, and no compound is approved for human or veterinary use except where explicitly stated under Regulatory status.
What the published research says about Melatonin
This section reports on published research referenced in BioRegen's own research library. It is not a claim by BioRegen that the compound provides any benefit, and nothing here is medical advice.
- Melatonin: Pharmacology, Functions and Therapeutic Benefits. Current Neuropharmacology (2017).
- Circadian Rhythm Dysregulation and Restoration: The Role of Melatonin. Nutrients (2021).